Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Express Scripts
Daiichi Sankyo
Queensland Health
Johnson and Johnson
US Department of Justice

Generated: December 14, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Hydralazine Hydrochloride, and what generic alternatives are available?

Hydralazine Hydrochloride is a drug marketed by Abraxis Pharm, Akorn, Fresenius Kabi Usa, Luitpold, Mylan Institutional, Navinta Llc, Smith And Nephew, Solopak, Teva Parenteral, X-gen Pharms Inc, Actavis Elizabeth, Actavis Grp Ptc, Alkem Labs Ltd, Anda Repository, Ascot, Cadila Pharms Ltd, Chartwell Rx, Glenmark Pharms Ltd, Halsey, Heritage Pharms Inc, Hetero Labs Ltd Iii, Impax Labs, Invagen Pharms, Ivax Sub Teva Pharms, Mutual Pharm, Mylan, Par Pharm, Pliva, Purepac Pharm, Quantum Pharmics, Strides Pharma, Superpharm, Tech Organized, Upsher-smith Labs, Usl Pharma, Vangard, Vitarine, Watson Labs, West Ward, Solvay, and Ivax Pharms. and is included in ninety-one NDAs.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Drug patent expirations by year for HYDRALAZINE HYDROCHLORIDE


US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Par PharmHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL086961-002Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
VangardHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL087712-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HalseyHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL089178-001Jan 15, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell RxHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL088848-001Feb 26, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Strides PharmaHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL200770-002May 3, 2013AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SuperpharmHYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazideCAPSULE;ORAL089201-001Feb 9, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Heritage Pharms IncHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL086242-004Feb 4, 2010AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SolvayHYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEhydralazine hydrochloride; hydrochlorothiazideCAPSULE;ORAL087213-001Feb 8, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL084443-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Heritage Pharms IncHYDRALAZINE HYDROCHLORIDEhydralazine hydrochlorideTABLET;ORAL086242-003Approved Prior to Jan 1, 1982AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: